Home Data Calendar Blog

MEDP

Tables

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Common Stock Value		0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.34	0.36	0.36	0.36	0.36	0.35	0.36	0.35	0.35	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.35	0.35	0.38	0.40	0.41	0.41	0.41	NA	NA	0.33	NA
Weighted Average Number Of Diluted Shares Outstanding		32.09	32.00	NA	31.76	31.57	32.16	NA	32.25	33.70	36.36	NA	37.52	37.71	37.75	NA	37.76	37.33	38.03	NA	37.84	37.39	37.28	NA	37.12	36.66	36.45	NA	39.33	40.83	41.51	NA	37.62	32.83	32.62	NA	31.43
Weighted Average Number Of Shares Outstanding Basic		30.99	30.84	NA	30.63	30.54	31.01	NA	31.01	32.49	34.92	NA	35.82	35.89	35.75	NA	35.55	35.39	36.02	NA	35.94	35.84	35.70	NA	35.57	35.52	35.49	NA	38.58	40.18	40.67	NA	37.12	32.64	32.62	NA	31.43
Earnings Per Share Basic		2.85	3.32	2.55	2.30	2.00	2.35	2.18	2.13	1.52	1.75	1.39	1.35	1.11	1.21	1.43	1.16	0.68	0.80	0.82	0.67	0.76	0.54	0.64	0.54	0.46	0.41	0.30	0.25	0.24	0.21	0.00	0.14	0.15	0.11	-0.27	0.00
Earnings Per Share Diluted		2.75	3.20	2.46	2.22	1.93	2.27	2.10	2.05	1.46	1.69	1.32	1.29	1.06	1.14	1.34	1.09	0.64	0.76	0.78	0.63	0.73	0.51	0.61	0.52	0.45	0.40	0.30	0.25	0.23	0.20	0.00	0.13	0.15	0.11	-0.27	0.00

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Revenue From Contract With Customer Excluding Assessed Tax		528.10	511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	106.61	108.24	107.80	105.95	99.59	96.04	92.13
Revenues		528.10	511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	0.00	108.24	107.80	105.95	99.59	96.04	92.13
Costs And Expenses		422.95	406.98	411.08	407.59	382.48	347.87	317.67	305.92	290.97	266.74	253.70	241.85	235.84	212.37	204.69	183.95	174.87	195.38	193.77	186.25	178.84	174.85	161.45	152.34	146.80	142.96	97.25	93.44	89.94	90.67	95.35	95.18	91.84	86.72	96.93	84.94
Selling General And Administrative Expense		41.45	44.08	42.51	41.41	39.40	38.03	33.40	35.42	33.22	29.37	27.66	28.05	26.97	25.74	22.38	22.80	21.86	25.12	21.26	29.12	23.56	21.31	20.57	18.61	20.51	16.00	16.84	16.61	14.76	15.15	16.78	16.39	14.82	13.51	18.25	15.29
Operating Income Loss		105.15	104.07	87.32	84.91	78.39	86.20	76.43	77.83	60.24	64.20	54.85	53.71	42.45	47.60	54.99	46.42	30.13	35.50	36.12	29.99	35.26	25.89	30.67	26.92	23.34	20.12	15.44	17.20	16.28	15.94	12.89	12.62	14.11	12.87	-0.89	7.20
Interest Income Expense Nonoperating Net		5.46	4.12	1.84	-0.10	-1.37	-0.86	-0.83	-1.58	-0.55	0.05	-0.02	-0.04	-0.03	-0.01	-0.03	-0.02	-0.01	0.36	0.39	-0.25	-0.75	-0.95	-1.60	-1.94	-2.31	-2.31	-2.05	-1.91	-1.81	-1.79	-2.83	-4.66	-5.92	-5.97	-6.55	-6.74
Income Tax Expense Benefit		22.13	10.19	12.41	12.65	14.68	13.14	4.97	15.87	12.64	4.01	5.89	6.16	2.75	5.20	3.84	5.53	6.26	7.52	6.40	5.49	7.04	5.46	6.56	6.15	4.95	3.11	2.38	5.32	4.79	5.33	0.25	2.55	3.23	2.51	0.94	0.64
Net Income Loss		88.35	102.59	78.30	70.55	61.07	72.89	68.67	66.03	49.36	61.31	50.03	48.57	39.93	43.31	50.87	41.46	24.10	28.95	29.81	23.98	27.45	19.20	22.76	19.30	16.57	14.55	11.29	9.83	9.55	8.45	-0.02	5.04	4.96	3.45	-8.58	-0.13
Comprehensive Income Net Of Tax		87.80	100.62	81.10	68.87	61.19	73.97	72.33	59.95	45.78	59.77	48.43	47.09	40.44	41.17	52.86	42.56	24.61	27.97	30.73	22.69	27.87	18.92	22.42	19.24	14.56	15.18	11.82	10.60	10.67	9.04	-1.39	5.21	4.40	4.02	-9.05	-0.26
Net Income Loss Available To Common Stockholders Basic		88.35	102.55	78.25	70.50	61.03	72.84	68.62	65.98	49.33	61.27	49.99	48.42	39.81	43.17	50.66	41.33	24.04	28.88	29.73	23.91	27.38	19.14	22.67	19.23	16.50	14.49	11.24	9.81	9.54	8.44	-0.05	5.04	4.96	3.45	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Assets		1920.05	1795.79	1656.83	1486.72	1406.94	1395.72	1352.49	1328.42	1315.45	1344.35	1659.93	1577.14	1469.71	1451.36	1390.68	1296.14	1222.13	1137.63	1143.07	1072.33	1016.86	1006.52	967.93	949.84	968.18	973.02	950.72	948.88	963.65	966.09	979.11	976.49	NA	NA	984.04	NA
Liabilities		1156.45	1124.25	1097.88	1015.81	1015.88	1048.46	966.11	978.54	1032.20	739.33	707.01	679.06	617.83	592.43	584.90	504.51	484.06	419.83	416.79	380.32	358.81	384.62	378.23	388.45	428.10	461.95	447.19	398.63	356.29	345.11	368.39	365.95	NA	NA	570.57	NA
Liabilities And Stockholders Equity		1920.05	1795.79	1656.83	1486.72	1406.94	1395.72	1352.49	1328.42	1315.45	1344.35	1659.93	1577.14	1469.71	1451.36	1390.68	1296.14	1222.13	1137.63	1143.07	1072.33	1016.86	1006.52	967.93	949.84	968.18	973.02	950.72	948.88	963.65	966.09	979.11	976.49	NA	NA	984.04	NA
Stockholders Equity		763.60	671.54	558.95	470.91	391.06	347.26	386.39	349.88	283.25	605.02	952.93	898.09	851.88	858.93	805.78	791.63	738.07	717.80	726.28	692.01	658.05	621.90	589.70	561.39	540.08	511.07	503.53	550.25	607.36	620.98	610.71	610.54	NA	NA	413.47	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Assets Current		872.52	744.90	593.83	448.88	378.93	367.62	333.96	337.74	328.89	355.97	690.91	641.22	550.10	533.38	473.65	395.00	319.08	303.00	317.03	250.40	194.34	182.38	178.11	153.09	158.48	153.75	129.97	117.03	123.12	128.32	133.25	120.53	NA	NA	94.72	NA
Cash And Cash Equivalents At Carrying Value		510.89	407.01	245.45	95.21	39.14	46.92	28.27	31.01	42.55	82.84	461.30	398.39	339.01	332.88	277.77	219.23	160.90	134.00	131.92	79.29	20.10	30.13	23.27	22.24	22.23	22.25	26.48	24.17	29.05	29.32	37.10	14.64	NA	NA	14.88	40.63
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		510.89	407.01	245.45	95.21	39.14	46.92	28.27	31.01	42.55	82.84	461.30	398.39	339.01	332.88	277.77	219.23	160.90	134.00	131.92	79.29	20.10	30.13	23.28	22.25	22.24	22.25	26.49	24.25	29.33	29.61	37.41	18.00	17.04	NA	17.74	NA
Receivables Net Current		301.11	279.17	298.40	292.77	275.06	257.75	253.40	249.09	225.69	224.76	186.43	186.38	161.49	160.00	160.96	134.09	127.29	136.37	155.66	140.19	149.86	129.62	133.45	108.28	115.40	110.65	83.08	74.71	76.66	82.28	79.77	81.92	NA	NA	65.09	NA
Prepaid Expense And Other Assets Current		60.52	58.73	49.98	60.90	64.73	62.95	52.29	57.65	60.64	48.37	43.18	56.45	49.60	40.51	34.92	41.69	30.89	32.63	29.45	30.92	24.39	22.62	21.38	22.55	20.84	20.85	20.40	18.07	17.13	16.43	16.07	20.61	NA	NA	11.90	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Property Plant And Equipment Gross		NA	NA	199.99	NA	NA	NA	171.97	NA	NA	NA	144.25	NA	NA	NA	124.12	NA	NA	NA	78.92	NA	NA	NA	85.37	NA	NA	NA	74.86	NA	NA	NA	61.43	NA	NA	NA	48.19	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA	NA	79.40	NA	NA	NA	62.12	NA	NA	NA	51.10	NA	NA	NA	39.11	NA	NA	NA	31.63	NA	NA	NA	33.11	NA	NA	NA	26.12	NA	NA	NA	17.63	NA	NA	NA	10.67	NA
Amortization Of Intangible Assets		0.36	0.36	0.55	0.55	0.55	0.55	0.84	0.84	0.84	0.84	1.28	1.28	1.28	1.28	1.95	1.95	1.98	2.00	3.00	3.00	3.00	5.84	7.39	7.39	7.39	7.39	9.49	9.50	9.46	9.45	12.67	12.67	12.67	12.67	13.12	15.77
Property Plant And Equipment Net		122.39	118.60	120.59	114.76	114.82	113.75	109.85	104.72	103.54	98.53	93.15	87.70	86.19	84.50	85.02	71.47	65.95	50.02	47.29	43.72	39.75	37.64	52.26	52.03	52.36	51.08	48.74	45.90	45.24	44.98	43.80	41.34	NA	NA	37.51	NA
Goodwill		662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.40	662.46	662.43	662.43	662.40	662.43	662.43	662.38	660.98	660.98	660.98	660.98	660.98	660.98	660.98	660.98	660.98	660.98	NA	NA	660.98	NA
Intangible Assets Net Excluding Goodwill		35.09	35.45	35.81	36.36	36.91	37.46	38.01	38.85	39.68	40.52	41.36	42.64	43.92	45.20	46.47	48.42	50.37	52.35	54.35	57.34	60.34	63.34	69.18	76.57	83.96	91.35	98.74	108.23	117.68	126.62	136.07	148.74	NA	NA	186.74	NA
Finite Lived Intangible Assets Net		3.44	3.80	4.16	4.71	5.26	5.81	6.36	7.20	8.04	8.88	9.71	10.99	12.27	13.55	14.83	16.78	18.73	20.71	22.70	25.70	28.69	31.69	37.53	44.92	52.31	59.70	67.09	76.59	86.03	94.98	104.42	117.09	NA	NA	155.10	NA
Other Assets Noncurrent		18.45	20.41	24.97	20.83	22.26	22.03	21.13	18.63	19.12	19.48	17.42	16.48	15.83	13.06	8.79	8.77	10.26	10.68	9.48	5.67	7.88	6.83	6.69	6.73	6.43	5.89	5.94	5.61	5.09	5.03	4.90	4.76	NA	NA	3.93	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Liabilities Current		993.09	956.64	925.13	848.52	852.44	881.89	803.47	820.87	878.96	579.43	557.22	517.18	472.61	447.31	440.11	358.40	337.98	338.65	343.00	314.39	296.07	264.54	257.03	232.13	233.16	232.49	192.71	172.36	155.26	150.04	168.60	156.59	NA	NA	134.02	NA
Accounts Payable Current		27.39	24.40	31.87	29.02	33.61	37.11	33.07	28.25	28.80	25.43	25.68	25.05	23.33	21.35	26.55	15.88	14.88	16.98	22.40	20.68	22.69	13.63	16.74	13.60	16.86	17.92	16.67	9.97	7.20	8.35	10.91	9.34	NA	NA	8.73	NA
Other Accrued Liabilities Current		9.29	13.66	11.28	11.28	9.75	11.55	10.51	13.00	11.59	9.27	9.60	10.14	9.21	8.56	7.07	6.03	5.46	8.49	6.44	7.28	4.78	5.74	5.04	4.89	4.90	4.26	3.97	3.10	3.20	3.40	2.96	3.05	NA	NA	2.92	NA
Accrued Liabilities Current		292.66	270.93	292.96	264.79	231.93	201.20	210.12	204.12	173.19	155.02	159.29	158.21	145.85	123.61	134.37	117.00	102.95	107.00	109.25	102.53	93.60	82.25	87.49	80.33	72.92	63.58	23.67	20.09	16.39	14.08	24.42	21.41	NA	NA	20.11	NA
Other Liabilities Current		34.62	44.62	40.44	35.95	41.35	62.54	47.55	30.88	25.90	31.75	27.61	30.07	21.22	24.54	23.53	22.91	24.80	25.10	18.99	21.64	14.33	18.43	4.86	4.79	5.93	8.11	4.70	5.25	3.13	5.26	3.28	4.76	NA	NA	7.53	NA
Contract With Customer Liability Current		638.42	616.70	559.86	518.75	490.56	466.04	462.73	417.93	401.37	367.22	344.64	303.85	282.22	277.81	255.66	202.61	195.35	189.56	192.36	169.53	165.45	150.24	147.94	133.40	120.94	NA	73.76	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Deferred Income Tax Liabilities Net		2.29	2.36	2.40	1.13	1.10	1.09	1.07	0.91	1.00	1.05	1.08	17.60	16.24	14.88	13.55	19.86	15.34	NA	12.85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Liabilities Noncurrent		29.27	29.08	28.22	23.12	22.95	22.79	22.70	17.56	17.26	17.22	17.75	16.06	16.13	16.11	16.09	15.59	15.76	15.77	15.72	14.33	14.40	14.62	12.80	11.01	10.68	10.44	10.74	8.54	8.34	8.09	7.97	5.25	NA	NA	7.29	NA
Operating Lease Liability Noncurrent		131.80	136.16	142.12	143.04	139.39	142.69	138.87	139.20	134.98	141.62	130.97	128.21	112.85	114.14	115.14	110.67	114.98	51.40	45.21	46.02	43.73	46.24	0.00	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Stockholders Equity		763.60	671.54	558.95	470.91	391.06	347.26	386.39	349.88	283.25	605.02	952.93	898.09	851.88	858.93	805.78	791.63	738.07	717.80	726.28	692.01	658.05	621.90	589.70	561.39	540.08	511.07	503.53	550.25	607.36	620.98	610.71	610.54	NA	NA	413.47	NA
Common Stock Value		0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.34	0.36	0.36	0.36	0.36	0.35	0.36	0.35	0.35	0.36	0.36	0.36	0.36	0.36	0.36	0.36	0.35	0.35	0.38	0.40	0.41	0.41	0.41	NA	NA	0.33	NA
Additional Paid In Capital Common Stock		818.90	814.65	802.68	795.99	785.29	778.69	770.79	759.99	753.30	746.12	727.86	721.60	716.55	707.88	695.90	687.62	676.62	673.37	666.59	663.04	651.78	643.50	639.38	636.54	634.47	632.37	630.34	628.56	627.41	625.30	623.63	NA	NA	NA	NA	NA
Retained Earnings Accumulated Deficit		-30.79	-119.14	-221.65	-300.20	-371.02	-408.10	-359.83	-380.12	-446.14	-120.81	234.98	184.95	142.31	158.53	115.23	111.81	70.35	53.83	68.11	38.30	14.32	-13.14	-41.49	-67.29	-86.60	-115.52	-120.40	-77.42	-18.42	-1.58	-9.58	-9.56	NA	NA	-23.01	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		-12.59	-12.04	-10.07	-12.87	-11.19	-11.31	-12.39	-16.05	-9.97	-6.39	-4.85	-3.24	-1.76	-2.27	-0.13	-2.12	-3.22	-3.73	-2.74	-3.66	-2.38	-2.79	-2.52	-2.18	-2.12	-0.10	-0.73	-1.26	-2.03	-3.15	-3.74	-2.38	NA	NA	-2.56	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		3.59	4.31	NA	5.01	4.91	5.44	NA	5.79	5.65	4.37	NA	4.05	3.57	2.87	NA	2.76	2.62	5.45	NA	9.47	5.38	3.18	NA	1.43	1.49	1.47	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Operating Activities		116.40	152.68	156.40	114.39	82.52	80.08	136.68	108.49	96.62	46.26	70.89	72.35	62.76	57.32	105.50	59.76	44.27	49.15	56.94	64.29	46.63	34.01	39.44	52.50	41.34	23.30	28.65	39.00	NA	NA	NA	NA	NA	NA	NA	NA
Net Cash Provided By Used In Investing Activities		-12.79	2.53	-8.00	-8.66	-8.47	-9.50	-9.22	-7.19	-11.13	-11.21	-9.12	-6.60	-6.00	-9.65	-7.73	-8.64	-9.31	-5.52	-5.73	-6.13	-3.44	-3.84	-4.21	-2.79	-6.04	-3.93	-3.38	-2.35	NA	NA	NA	NA	NA	NA	NA	NA
Net Cash Provided By Used In Financing Activities		0.67	7.66	1.52	-49.27	-82.21	-52.68	-131.12	-109.11	-123.46	-412.08	2.43	-5.21	-50.78	9.10	-40.21	6.78	-8.41	-40.45	0.83	1.79	-53.52	-23.03	-33.85	-49.75	-33.98	-24.01	-23.23	-42.14	NA	NA	NA	NA	NA	NA	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Operating Activities		116.40	152.68	156.40	114.39	82.52	80.08	136.68	108.49	96.62	46.26	70.89	72.35	62.76	57.32	105.50	59.76	44.27	49.15	56.94	64.29	46.63	34.01	39.44	52.50	41.34	23.30	28.65	39.00	NA	NA	NA	NA	NA	NA	NA	NA
Net Income Loss		88.35	102.59	78.30	70.55	61.07	72.89	68.67	66.03	49.36	61.31	50.03	48.57	39.93	43.31	50.87	41.46	24.10	28.95	29.81	23.98	27.45	19.20	22.76	19.30	16.57	14.55	11.29	9.83	9.55	8.45	-0.02	5.04	4.96	3.45	-8.58	-0.13
Increase Decrease In Other Operating Capital Net		8.53	-5.86	-4.05	5.93	22.70	-14.98	-21.57	-5.22	6.22	-1.49	3.54	-8.30	4.89	0.42	-0.88	1.30	1.05	-3.44	5.45	-7.81	6.01	-5.77	-2.53	1.17	2.52	-3.09	-1.72	-1.25	2.08	-1.88	-1.53	0.18	2.76	-0.57	-2.24	NA
Increase Decrease In Accounts Payable		4.90	-7.35	1.97	-3.26	-2.12	4.46	5.66	-1.78	3.59	-1.04	-0.28	2.42	2.37	-2.64	3.01	1.56	-0.36	-6.81	1.91	-2.52	8.02	-2.68	2.67	-2.70	0.68	0.70	5.28	2.39	-1.52	-1.33	1.63	1.17	-0.09	-2.03	1.64	NA
Deferred Income Tax Expense Benefit		-0.05	-0.86	-13.81	-7.60	-2.65	-1.06	-20.89	-0.69	-0.73	-0.71	-40.41	0.63	1.38	1.29	-6.38	4.50	1.34	1.08	7.21	1.00	1.18	0.66	-3.32	7.55	-0.04	-0.25	3.66	0.44	-0.45	-0.41	-8.44	-0.09	-0.17	-0.31	-4.38	NA
Share Based Compensation		3.59	4.31	5.17	5.01	4.91	5.44	5.59	5.79	5.65	4.37	3.98	4.05	3.57	2.87	2.96	2.76	2.62	5.45	2.71	9.47	5.38	3.18	2.11	1.43	1.49	1.47	1.25	0.98	1.20	1.03	1.26	4.28	3.27	1.01	10.49	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Investing Activities		-12.79	2.53	-8.00	-8.66	-8.47	-9.50	-9.22	-7.19	-11.13	-11.21	-9.12	-6.60	-6.00	-9.65	-7.73	-8.64	-9.31	-5.52	-5.73	-6.13	-3.44	-3.84	-4.21	-2.79	-6.04	-3.93	-3.38	-2.35	NA	NA	NA	NA	NA	NA	NA	NA
Payments To Acquire Property Plant And Equipment		12.87	5.50	9.99	8.70	8.45	9.51	9.24	7.18	11.20	9.26	9.12	6.64	6.01	6.51	7.79	8.67	9.32	5.56	5.76	6.16	3.47	2.52	3.45	2.78	5.84	3.95	3.40	2.31	1.65	4.37	5.69	2.15	2.24	3.46	1.78	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Net Cash Provided By Used In Financing Activities		0.67	7.66	1.52	-49.27	-82.21	-52.68	-131.12	-109.11	-123.46	-412.08	2.43	-5.21	-50.78	9.10	-40.21	6.78	-8.41	-40.45	0.83	1.79	-53.52	-23.03	-33.85	-49.75	-33.98	-24.01	-23.23	-42.14	NA	NA	NA	NA	NA	NA	NA	NA
Payments For Repurchase Of Common Stock		NA	NA	0.00	0.00	23.87	120.15	47.18	0.00	374.72	425.95	0.00	6.22	NA	NA	47.45	0.00	9.05	41.78	NA	NA	0.00	0.00	0.00	0.00	NA	NA	60.32	68.86	26.40	NA	0.00	0.00	NA	NA	NA	NA

		2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30
Revenues		528.10	511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	0.00	108.24	107.80	105.95	99.59	96.04	92.13
Revenue From Contract With Customer Excluding Assessed Tax		528.10	511.04	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	192.12	179.25	170.14	163.08	112.68	110.64	106.22	106.61	108.24	107.80	105.95	99.59	96.04	92.13
Cin Rx Pharma And Subsidiaries, Revenue Net, Related Party Service Agreement, Related Party		NA	NA	4.40	5.30	3.60	NA	1.20	0.50	7.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
L I B Therapeutics L L C And Subsidiaries, Revenue Net, Related Party Service Agreement, Related Party		NA	NA	10.60	10.10	9.70	NA	13.90	9.50	9.70	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Cin Rx Pharma And Subsidiaries, Related Party Service Agreement, Related Party		7.30	6.30	NA	NA	3.60	2.50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
L I B Therapeutics L L C And Subsidiaries, Related Party Service Agreement, Related Party		3.90	6.50	NA	NA	9.70	13.30	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Antiviral And Anti Infective		39.20	44.03	48.89	45.55	36.01	32.87	29.69	31.45	25.58	31.32	26.93	27.03	26.19	30.82	27.88	27.24	22.99	25.15	19.56	24.24	22.66	19.92	17.78	22.10	20.19	16.68	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Cardiology		60.70	55.64	51.58	44.36	51.13	46.62	45.41	49.80	42.03	37.40	33.15	34.74	28.04	23.76	19.91	27.59	21.75	25.90	22.47	21.73	22.14	20.42	22.52	21.06	24.51	23.74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Central Nervous System		46.52	44.14	39.65	43.99	37.73	38.70	37.13	43.42	38.91	38.49	35.33	32.85	28.55	24.81	23.45	21.75	19.22	23.98	17.05	16.33	16.79	14.87	13.80	13.83	13.11	13.16	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Metabolic		106.30	103.64	99.02	103.12	87.86	86.84	77.49	63.48	55.60	48.12	47.13	42.13	38.14	32.49	30.17	29.62	30.21	36.08	36.36	34.92	31.49	33.74	26.25	22.93	22.89	22.05	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Oncology		162.95	155.20	148.73	149.33	147.09	141.95	124.21	122.83	115.54	105.21	95.74	94.72	93.25	79.14	94.20	68.63	65.63	69.21	70.61	65.53	64.62	55.96	53.23	48.94	43.00	43.85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other		112.43	108.40	110.53	106.16	101.06	87.10	80.17	72.77	73.56	70.42	70.27	64.09	64.12	68.94	64.06	55.54	45.20	50.57	63.84	53.48	51.94	51.32	48.45	41.46	37.06	34.22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue Net		NA	NA	498.40	492.50	460.87	434.07	394.10	383.74	351.21	330.95	308.55	295.57	278.29	259.96	259.68	230.37	205.00	230.88	229.89	216.24	214.10	200.74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Related Party		11.20	12.80	15.00	15.50	13.30	15.80	15.10	9.80	17.20	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept